• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.

作者信息

Tan Ying, Cao Lei, Lv Ji-Cheng, Yan Yu, Zuo Li, Wang Mei, Yu Lu, Yu Feng, Zhao Ming-Hui

出版信息

Thromb Haemost. 2009 Dec;102(6):1282-4. doi: 10.1160/TH09-05-0304.

DOI:10.1160/TH09-05-0304
PMID:19967164
Abstract
摘要

相似文献

1
Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis.抗肝素血小板因子4抗体与维持性血液透析患者的动脉和静脉血栓形成有关。
Thromb Haemost. 2009 Dec;102(6):1282-4. doi: 10.1160/TH09-05-0304.
2
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.慢性血液透析患者中血小板因子4-肝素复合物抗体的患病率及其与血管通路血栓形成的关联。
Thromb Res. 2007;120(2):215-20. doi: 10.1016/j.thromres.2006.09.014. Epub 2006 Nov 13.
3
P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment.肝素治疗7天后静脉或动脉疾病患者的P-选择素及抗肝素-血小板因子4抗体
J Am Coll Surg. 2004 Jul;199(1):69-77. doi: 10.1016/j.jamcollsurg.2004.02.027.
4
Delayed-onset heparin-induced thrombocytopenia and thrombosis.迟发性肝素诱导的血小板减少症和血栓形成。
Ann Intern Med. 2001 Oct 2;135(7):S-45.
5
The presence of antibodies against a PF4-heparin complex in patients on haemodialysis.血液透析患者中抗PF4-肝素复合物抗体的存在情况。
Thromb Haemost. 1996 Sep;76(3):480.
6
Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.抗肝素-血小板因子4复合物抗体：血液透析中肝素诱导的血小板减少症的发病机制、流行病学及管理
Am J Kidney Dis. 2009 Aug;54(2):361-74. doi: 10.1053/j.ajkd.2009.03.012. Epub 2009 May 29.
7
Role of platelet factor 4-heparin complex antibody (HIT antibody) in the pathogenesis of thrombotic episodes in patients on hemodialysis.血小板第4因子-肝素复合物抗体（HIT抗体）在血液透析患者血栓形成发作发病机制中的作用。
Hemodial Int. 2005 Oct;9 Suppl 1:S2-7. doi: 10.1111/j.1542-4758.2005.01163.x.
8
Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.因血栓形成前往急诊科就诊患者体内的肝素-血小板第4因子抗体
Am J Emerg Med. 2007 Mar;25(3):279-84. doi: 10.1016/j.ajem.2006.07.015.
9
Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up.接受普通肝素治疗的患者发生肝素诱导的血小板减少症：1年随访期内血栓形成的发生率
Ital Heart J. 2000 Jan;1(1):39-42.
10
Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke.磺达肝癸钠血栓预防相关的肝素诱导的血小板减少症综合征并发动脉血栓性中风。
Thromb Haemost. 2010 Nov;104(5):1071-2. doi: 10.1160/TH10-05-0284. Epub 2010 Aug 30.

引用本文的文献

1
The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients.终末期肾病患者血栓炎症生物标志物的相关性及其与循环糖胺聚糖的关系。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231169512. doi: 10.1177/10760296231169512.